lung cancer objectives
play

Lung Cancer Objectives To provide a general overview of lung physiology To explore the types and classifications of lung cancer To provide causes and risk factors of lung cancer To present the signs and symptoms of lung cancer in throughout

0 downloads 1 Views 1,93 MB Size Report
  1. Lung Cancer

  2. Objectives To provide a general overview of lung physiology To explore the types and classifications of lung cancer To provide causes and risk factors of lung cancer To present the signs and symptoms of lung cancer in throughout its progression To explore assessment and diagnostic information of lung cancer To introduce diagnostic staging specific to lung cancer To discuss treatments and side effects of lung cancer To present post-op complications for cases with lung cancer

  3. General Overview of Lung Physiology: Breathing

  4. Healthy lung tissue

  5. Diseased Lung Tissue

  6. Types of Lung Cancer Two main Types of Lung Cancer : Small Cell Lung Cancer (20-25% of all lung cancers) Non Small Cell Lung Cancer (most common ~ 80%)

  7. Small Cell Lung Cancer

  8. Non-small cell lung cancer • 1. Squamous cell carcinoma • 2. Adenocarcinoma • 3. Large cell carcinomas

  9. Squamous cell carcinoma • Moderate to poor differentiation • makes up 30-40% of all lung cancers • more common in males • most occur centrally in the large bronchi • Uncommon metastasis that is slow effects the liver, adrenal glands and lymph nodes. • Associated with smoking • Not easily visualized on xray (may delay dx) • Most likely presents as a Pancoasts tumor

  10. Adenocacinoma • Increasing in frequency. Most common type of Lung cancer (40-50% of all lung cancers). • Clearly defined peripheral lesions (RLL lesion) • Glandular appearance under a microscope • Easily seen on a CXR • Can occur in non-smokers • Highly metastatic in nature – Pts present with or develop brain, liver, adrenal or bone metastasis

  11. Large cell carcinomas • makes up 15-20% of all lung cancers • Poorly differentiated cells • Tends to occur in the outer part (periphery) of lung, invading sub-segmental bronchi or larger airways • Metastasis is slow BUT • Early metastasis occurs to the kidney, liver organs as well as the adrenal glands http://www.youtube.com/watch?v= 3wzjqbh besI.

  12. Lung Cancer Re-cap Small Cell Lung Cancer Non-Small-Cell Lung Cancer Squamous cell Adenocarinoma

  13. Causes and Risk factors of Lung Cancer

  14. Signs and Symptoms of Lung Cancer Sometimes lung cancer does not cause any symptoms and is only found in a routine x-ray. If a person with lung cancer does have symptoms, they will depend on the location of the tumour in their lung. It is also imperative to note that the same symptoms can be caused by other conditions, so may not necessarily mean cancer. Therefore it is important to consult a doctor when symptoms are present. Signs and symptoms also depend upon the location, size of the tumor, degree of obstruction and existence of metastases

  15. Signs and Symptoms of Lung Cancer There are two types of signs and symptoms of lung cancer: ) Localized – involving the lung. ) Generalized – involves other areas throughout the body if the cancer has spread.

  16. ocalized Signs and Symptoms ugh eathing Problems, SOB, stridor ange in phlegm ng infection, hemoptysis oarseness, Hiccups t loss est Pain and tightness ncoats Syndrome orner’s Syndrome eural Effusion perior Vena Cava Syndrome tigue

  17. Generalized Signs and Symptoms Bone pain Headaches, mental status changes or neurologic findings Abdominal pain, elevated liver function tests, enlarged liver, gastrointestinal disturbances (anorexia, cachexia), jaundice, hepatomegaly r/t liver involvement Weight loss

  18. arly/late Signs and Symptoms Of ung Cancer Early Signs Late signs Cough/chronic cough Bone pain, spinal cord compression Dyspnea Chest pain/tightness Hemoptysis Dysphagia Chest/shoulder pain Head and neck edema Recurring temperature Blurred vision, headaches Recurring respiratory Weakness, anorexia, infections weight-loss, cachexia Pleural effusion

  19. Diagnostic Tests • CXR • CT Scans • MRI • Sputum cytology • Fibreoptic bronchoscopy • Transthoracic fine needle aspiration

  20. aboratory Tests  Blood Tests * CBC-to check red/white blood cell & platelets -to check bone marrow and organ function * Blood Chemistry Test-to assess how organs are functioning such as liver and kidney  Biopsy-to determine if the tumor is cancer or not -to determine the type of cancer -to determine the grade of cancer (slow or fast)

  21. Biopsy

  22. Endoscopy Bronchoscopy Mediastinoscopy VATS (video assisted thoracoscopic surgery)

  23. Bronchoscopy

  24. Mediastinoscopy

  25. horacoscopic surgery) VATS (video assisted

  26. ursing Management for post ndoscopic procedures onchoscopy Mediastinoscopy VATS onitor V/S; NPO status Monitor VS; potential for Monitor V/S; potential aintained until return bleeding, infection and for bleeding, infection gag reflex. dyspnea; NPO status and dyspnea; NPO status until return of gag reflex until return of gag reflex ver up to 101F can be pected afterwards

  27. Post-op complications for those with lung cancer Airway obstruction, dyspnea, hypoxemia, respiratory failure Anesthesia side effects (N/V) Bleeding (hypotension, cardiogenic shock) Cardiac dysthymias, CHF, fluid overload Fever, sepsis Pneumonia Pneumothorax Pulmonary embolus Wound dehiscence Prolonged hospitalization Death

  28. Nursing pulmonary post-op onsiderations/interventions Positioning in bed, Monitor V/S Prevention of respiratory complications – Early ambulation, DB&C, incentive spirometer, managing dyspnea Prevention of deep vein thrombosis – Early ambulation Pain management Infection control

  29. Educating the patient Inform the patient what to expect, from administration of anesthesia to thoracotomy and the likely use of chest tubes and a drainage system postoperatively. Tell the patient about the administration of oxygen postoperatively and the possible use of a ventilator. Explain the importance of frequent turning to promote drainage of lung secretions. Instruct the proper use of an incentive spirometry and how to perform diaphragmatic and pursed-lip breathing techniques. Teach the patient to splint the incision site with hands, a pillow or a folded towel to avoid discomfort

  30. Cancer Staging nical Staging Pathological Based on the examination of the based on findings gathered by • tissue samples obtained from the the doctor primary tumor, nodes or metastasis used to plan the initial therapy Helpful in planning additional • may be modified by additional treatment and follow-up nformation found during pathological examination

  31. Cancer Staging Systems • The most common staging system for lung cancer is the TNM System developed by the International Union Against Cancer (UICC). • Guides best course of treatment • Estimates prognosis • It is only useful in staging NSCLC, when surgery is considered.

  32. TMN Staging system for Lung Cancer = Tumors : tumor size, (local invasion) = Node : node involvement (size and type) = Metastasis : general involvement in organs and tissues

  33. ung Cancer Staging Continued T: Tx, T0, Tis, T1-T4 (T3- tumors greater than 7cm, T4 is a tumor of any size) N: N0, N1, N2, N3 M: M0, M1a, M1b

  34. Medical Management  The three main cancer treatments are: * surgery (lung resections) * radiation therapy * chemotherapy  Other types of treatment that are used to treat certain cancers are hormonal therapy, biological therapy or stem cell transplant.

  35. Side effects of treatments rgery Radiation Chemotherapy n fatigue Anemia, thrombocytopenia motomas Decreased nutritional Fatigue intake mmorhage Radiodermatitis Alopecia, SOB ered respiratory Decreased hematopoietic Cold, pale nction function sk for atelectasis, Risk for Pneumonitis, Tingling eumonia, hypoxia esophagitis, cough sk for DVT N/V Irritable Grief Dizzy, weak

  36. Lung resections Lobectomy: a single lobe of lung is removed Bilobectomy: 2 lobes of the lung are removed (only on R side) Sleeve resection: cancerous lobe is removed and segment of the main bronchus is resected Pneumonectomy: removal of entire lung Segmentectomy: a segment of the lung is removed Wedge resection: removal of a small, pie-shaped area of the segment Chest wall resection with removal of cancerous lung

  37. Prognostic Factors The best estimate on how a patient will do based on: * type of cancer cells * grade of the cancer * size or location of the tumor * stage of the cancer at the time of diagnosis * age of the person * gender * results of blood or other tests * a persons specific response to treatment * overall health and physical condition

  38. Prevention: Primary Avoid the use of tobacco smoke Personal and family hx are important risk factors Know environmental carcinogens that increase risk Chemoprevention: Consuming carotenoids, Vit A, retinoids Vit E, selenium, Vit C, fat

  39. Prevention: Secondary Aim is to early diagnose high risk populations via screening CXR, MRI, CT scans, sputum cytology

  40. Prevention: Tertiary Targeted at people who survived a cancer disease Assists them to retain an optimal level of functioning regardless of their potential debilitating disease

Recommend Documents


controversies in the surgical management of lung cancer
Controversies in the surgical

Controversies in the surgical management of lung cancer 14 th Annual Winter

lung cancer lung cancer lung cancer lung cancer improving
Lung Cancer : Lung Cancer : Lung

Lung Cancer : Lung Cancer : Lung Cancer : Lung Cancer : Improving the Cure

lung cancer screening and the women of tennessee
Lung Cancer Screening and the Women of

Lung Cancer Screening and the Women of Tennessee Kim. L. Sandler, MD

prognostic molecular models in early stage lung cancer
Prognostic molecular models in

Prognostic molecular models in early-stage lung cancer 14 th Annual Winter

improving the implementation of lung cancer screening
Improving the implementation of lung

Improving the implementation of lung cancer screening guidelines at UNC

lung cancer screening
LUNG CANCER SCREENING IMPROVING LUNG

8/19/2018 LUNG CANCER SCREENING IMPROVING LUNG CANCER SURVIVAL IN THE

navigating patients through lung cancer treatment
Navigating patients through lung

Navigating patients through lung cancer treatment Kirsten Mooney -Thoracic

lung cancer diagnosis in 2007
Lung Cancer Diagnosis in 2007

Lung Cancer Statistics, 2007 Lung Cancer Diagnosis in 2007 Greatest cause of

outline
Outline Changing lung cancer

UCSF Continuing Medical Education Disclosures Revolution Medicines

2011 trial update
2011 Trial Update RTOG Lung Cancer

RTOG Lung Cancer 2011 Trial Update RTOG Lung Cancer Committee Chair:

study of atherosclerosis mesa stress
Study of Atherosclerosis (MESA) Stress

Diurnal Cortisol Profile as a Predictor of Weight Change over 6 years: The

primary adrenal
Primary adrenal insufficiency

Primary adrenal insufficiency Addison's disease Dr. Jeff Muigai INTRODUCTION

analysis of avp functions via v1a and v1b receptors with
Analysis of AVP functions via V1a and

Analysis of AVP functions via V1a and V1b receptors with knockout mice Akito

the digestive system from a microbial perspective
The Digestive System From a Microbial

The Digestive System From a Microbial Perspective Good morning! For the last

jackie eberstein presenta0on sd 2016
Jackie Eberstein - Presenta0on (SD

Jackie Eberstein - Presenta0on (SD 2016) Dr. Eberstein: By show of

perinatal mental health conference
Perinatal Mental Health Conference

Perinatal Mental Health Conference Fairmont Hot Springs, Montana October

gastroesophageal adenocarcinoma promorec project
gastroesophageal adenocarcinoma

Comprehensive molecular analysis of recurrence in gastroesophageal

pattern and implication of lymphatic drainage in renal
Pattern and implication of lymphatic

Pattern and implication of lymphatic drainage in renal tumors Axel Bex, MD,

meet the experts
Meet the experts: Cardiogenic Shock

Meet the experts: Cardiogenic Shock Inotropes: effects on the heart, the

adrenaline fueled development racing with autonomous
Adrenaline Fueled Development: Racing

Adrenaline Fueled Development: Racing With Autonomous Vehicles Session: 23317

learning objectives
Learning Objectives Supporting the

4/18/2014 Learning Objectives Supporting the Special Needs of Develop an

mana managing p ging police str lice stress ss and and
Mana Managing P ging Police Str lice

Advanced Survival Training Mana Managing P ging Police Str lice Stress ss